TBX21 and Miyoshi myopathy: We formally assessed the predictive relationship between posttreatment CD8+ T cell TBX21 expression and clinical outcome using univariate Kaplan–Meier analysis across all ICB-treated patients with MM with an on-treatment sample taken at the second treatment cycle (after cycle 1, n = 181).